Maputo, 13 March 2018 - Bayer has officially kicked-off a one-year trial of a new malaria fighting Indoor Residual Spray (IRS), called Fludora Fusion, in Mozambique’s Manhica District. The trial, which is being run in partnership with The Manhica Health Research Centre and Goodbye Malaria, is one of 17 trials currently taking place in other sub Saharan Africa countries.more
• Field study delivers inconsistent results, highlighting the need to appropriately consider colony strength and environmental conditions.
• Study confirms neither bumble bee queen nor solitary bee egg cell production are “directly affected by the seed treatments”.
• Bayer remains convinced that neonicotinoid seed treatments for oilseed rape have no short- or long-term negative effects on bees and that these seed treatments are a useful and effective tool for farmers.more
Johannesburg, May 12, 2017 – Bayer has announced that applications are now open for its exciting Grant4Apps programme. Geared to connect health startups with industry experts and help the best talents to thrive within the digital healthcare universe, the programme will offer startups an opportunity to become part of an economically inclusive market where innovation is not only encouraged but appreciated as a catalyst for expanding both economic and social growth.more